It's that time of the year; We all likely indulged more than we'd like to admit for the holidays and put on a few extra ...

Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Semaglutide and other GLP-1 meds slow the rate at which food empties from your stomach, and that leaves you feeling full ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

In this randomized controlled trial, once-weekly semaglutide led to significant weight loss compared to placebo over 68 weeks ...